FIELD: chemistry.
SUBSTANCE: invention relates to a method of producing a compound of formula I-1, comprising steps of: a) reacting a compound of formula 6a* with a compound of formula 27 under suitable conditions for formation of an amide bond, where the corresponding amide bond formation conditions involve reacting a compound of formula 6a* with a compound of formula 27 in an aprotic solvent while heating to form a compound of formula 28; b) purifying compound of formula 28 using corresponding chelating agent for palladium selected from propane-1,2-diamine; ethane-1,2-diamine; ethane-1,2-diamine; propane-1,3-diamine; tetramethylethylenediamine; ethylene glycol; 1,3-bis(diphenylphosphanyl)propane; 1,4-bis(diphenylphosphanyl)butane and 1,2-bis(diphenylphosphanyl)ethane / Pr-1,2-diamine; c) reacting a compound of formula 28 under suitable deprotection conditions, where the corresponding deprotection conditions involve reacting a compound of formula 28 with an acid in the presence of a solvent to form a compound of formula 30; d) reacting a compound of formula 30 with a compound of formula 25 under suitable conditions for formation of an amide bond, where corresponding conditions for forming an amide bond include reacting a compound of formula 30 with a compound of formula 25 in the presence of a partner to form an amide bond, an aprotic solvent and a base to form a compound of formula I-1. Invention also relates to a method of producing a compound of formula I-1, comprising the steps of: a) reacting a compound of formula 5a under appropriate halogenation conditions, where the corresponding halogenation conditions involve reacting a compound of formula 5a with a halogenating agent and a base in the presence of a solvent to form a compound of formula 34; b) reacting a compound of formula 34 with a compound of formula 27 under suitable conditions for formation of an amide bond, where the corresponding conditions for forming an amide bond involve reacting a compound of formula 34 with a compound of formula 27 in an aprotic solvent while heating to form a compound of formula 28; c) reacting a compound of formula 28 under suitable deprotection conditions, where the corresponding deprotection conditions involve reacting a compound of formula 28 with an acid in the presence of a solvent to form a compound of formula 30; d) reacting a compound of formula 30 with a compound of formula 25 under suitable conditions for formation of an amide bond, where the corresponding amide bond formation conditions involve reacting a compound of formula 30 with a compound of formula 25 in the presence of a partner to form an amide bond, an aprotic solvent and a base to form a compound of formula I-1.
, , , , , , ,
EFFECT: novel methods of producing a compound of formula I-1, which can be used in medicine for use as an ATR protein kinase inhibitor.
15 cl, 12 tbl, 33 dwg, 19 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOUNDS APPLICABLE AS ATR KINASE INHIBITORS | 2020 |
|
RU2750148C1 |
COMPOUNDS SUITABLE FOR USE AS ATR KINASE INHIBITORS | 2014 |
|
RU2687276C2 |
INTEGRATED STRESS PATHWAY PRODRUG MODULATORS | 2019 |
|
RU2824500C2 |
C-ANILINOQUINAZOLINE COMPOUNDS AND THEIR USE IN CANCER TREATMENT | 2018 |
|
RU2769694C2 |
INDAZOLIE WNT SIGNAL PATHWAY INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS | 2017 |
|
RU2682245C1 |
PYRIDO[1,2-A]PYRIMIDONE ANALOG, ITS CRYSTAL FORM, ITS INTERMEDIATE COMPOUND AND METHOD FOR THEIR PREPARATION | 2016 |
|
RU2753696C2 |
PROCESSES FOR MAKING COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | 2012 |
|
RU2677292C2 |
3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND VARIANTS OF THEIR USE | 2018 |
|
RU2795850C2 |
PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS AS TAM AND MET KINASE INHIBITORS | 2019 |
|
RU2773611C1 |
BROMODOMAIN INHIBITORS | 2017 |
|
RU2741808C2 |
Authors
Dates
2020-04-29—Published
2014-12-05—Filed